European Metals Holdings (ASX:EMH) Cinovec Project is strategically located in the heart of the growing European EV ecosystem in the northwest of the Czech Republic. Cinovec is a large historic lithium resource, with a clean pathway to underground development. EMH’s 51 per cent JV partner is the national utility CEZ a subsidiary of CEZ Group, which is owned 70 per cent by the Czech Government.
Copyright 2023 – Finance News Network
21 Mar 2023 - Aspen Group Limited (ASX:APZ) Executive Director and Joint CEO John Carter provides an introduction to the company, discussing target market, the rising interest rate environment, portfolio mix and development pipeline.
07 Jun 2023 - Larvotto Resources Limited (ASX:LRV) Managing Director Ron Heeks discusses the company's projects, commenting on their rare earths, gold, copper, cobalt, lithium and PGE potential.
27 Aug 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes provides an update on sales and distribution for the company's Automated Plate Assessment System (APAS), which is used to read culture plates in laboratories.
23 June 2020 - Renergen Limited (ASX:RLT) Managing Director Stefano Marani talks about the significance of the company's marketing and distribution agreement with Total South Africa for LNG from Phase 1 of its project.
27 Jun 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company's lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial.
11 Apr 2023 - Lifestyle Communities Limited (ASX:LIC) CFO Darren Rowland provides an introduction to the company, discussing business model and service, market positioning and growth opportunities.
03 Nov 2022 - Antisense Therapeutics Limited (ASX:ANP) Chair, Dr Charmaine Gittleson, and new Chief Commercial Officer, Dr Anthony Filippis, discuss Antisense's progress, attracting new talent to the company, and what drew Dr Filippis to the role.
30 Mar 2022 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses the company's LAG-3-related therapies, outlining future plans and expected data readouts for Immutep's lead drug, eftilagimod alpha.
17 Feb 2023 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari discusses the company's upcoming plans to list on the NASDAQ and provides an update on the its clinical trials.
